We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Draft Guidance on Trial Design for Clinical Lactation Studies
FDA Releases Draft Guidance on Trial Design for Clinical Lactation Studies
February 10, 2005
Drugmakers seeking approval of a product intended for use in women of reproductive age should conduct lactation studies on the drug, even in cases when the product would rarely be used in lactating women, according to a new FDA draft guidance.